Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Third-quarter 2026 sales rose 5.9% year over year to $25.4 billion. Adjusted diluted EPS was $2.59; reported diluted EPS was $0.09, reflecting one-time special items. The company raised full-year 2026 guidance.
For best results when printing this announcement, please click on link below: Johnson & Johnson reports Q3 2026 results, raises 2026 guidance 2026 Third-Quarter reported sales growth of 5.9% to $25.4 Billion with operational growth of 6.0%* and adjusted operational growth of 6.1% 2026 Third-Quarter earnings per share (